Skip to content
DataLookout
Menu

Suzhou Suncadia Biopharmaceuticals Co., Ltd. clinical trial pipeline

Get alerts when Suzhou Suncadia Biopharmaceuticals Co., Ltd.'s trials change
Data updated daily from ClinicalTrials.gov, last refresh 2026-11-19

What changed in the last 30 days

6 trials changed in the last 30 days: 0 stopped, 5 with notable changes, 1 with a minor change only.

  1. Notable: SHR-A2009 Combined With Other Anti-tumor Therapies for Perioperative Treatment of Resectable Non-small Cell Lung Cancer Recruitment opened Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 2 NCT07863167
  2. Notable: Treatment of MIBC · SHR-A2102 Injection Combined With Adebrelimab (SHR-1316) Primary endpoint(s) modified Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 2/3 NCT06879145
  3. Minor: SHR-1701 in Combination With Chemotherapy and Radiotherapy in Locally Advanced Rectal Cancer Changed Registry marked status Unknown (sponsor has not verified the record since Mar 2022); last known: Recruiting Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 2 NCT05300269
  4. Notable: Trials Comparing Trastuzumab Plus Bevacizumab With Bevacizumab as First-line Maintenance Therapy for Epithelial Ovarian Cancer Recruitment opened Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3 NCT07779538
  5. Notable: SHR-4595 Injection · Advanced Solid Tumors to Evaluate Safety, Tolerability and Pharmacokinetics Recruitment opened Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 1 NCT07830199
  6. Notable: TACE in Combination With SHR-8068, Adebrelimab, and Bevacizumab Versus TACE · Incurable Hepatocellular Carcinoma Start date pushed from Sep 2026 to Nov 2026 Suzhou Suncadia Biopharmaceuticals Co., Ltd.Phase 3 NCT07691762
  • Stopped: terminated, suspended or withdrawn
  • Notable: the plan changed
  • Minor: routine updates

New trial filings, last 30 days

First postedTrialPhaseStatus
2026-10-26 NCT07895992 SHR-A2009 Combined With Bevacizumab in the Treatment of Locally Advanced or Metastatic… Phase 3 Not Yet Recruiting
2026-10-26 NCT07896005 A Study of SHR-A1811 Combined With Adebrelimab for the First-line HER2-overexpressing… Phase 3 Not Yet Recruiting

Active trials by phase

Phase 1
18
Phase 1/2
13
Phase 2
15
Phase 2/3
2
Phase 3
24
Phase 4
1

Disease areas by active trials, top 10 of 23

Get alerts when Suzhou Suncadia Biopharmaceuticals Co., Ltd.'s trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free